Prot #c11-092: NU MSK13U01: A Phase 2, Randomized, 3-Arm Study of Abiraterone Acetate Alone, Abiraterone Acetate Plus Degarelix, A GnRH Antagonist, and Degarelix Alone for Patients with Prostate Cancer with a Rising PSA Or A Rising PSA and Nodal Disease F

  • Kuzel, Timothy Michael (PD/PI)

Project: Research project

Project Details

StatusFinished
Effective start/end date11/14/1311/14/16

Funding

  • Janssen Biotech, Inc. (Prot #c11-092: NU MSK13U01 // Prot #c11-092: NU MSK13U01)
  • Memorial Sloan-Kettering Cancer Center (Prot #c11-092: NU MSK13U01 // Prot #c11-092: NU MSK13U01)